These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1233 related articles for article (PubMed ID: 18802025)
1. Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation. Das S; Wong R; Rajapakse N; Murphy E; Steenbergen C Circ Res; 2008 Oct; 103(9):983-91. PubMed ID: 18802025 [TBL] [Abstract][Full Text] [Related]
2. Overcoming an energy crisis?: an adaptive role of glycogen synthase kinase-3 inhibition in ischemia/reperfusion. Zhai P; Sadoshima J Circ Res; 2008 Oct; 103(9):910-3. PubMed ID: 18948628 [No Abstract] [Full Text] [Related]
3. Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK-3beta: interaction with the MPT pore. Mozaffari MS; Schaffer SW Am J Hypertens; 2008 May; 21(5):570-5. PubMed ID: 18437149 [TBL] [Abstract][Full Text] [Related]
5. Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore. Xi J; Wang H; Mueller RA; Norfleet EA; Xu Z Eur J Pharmacol; 2009 Feb; 604(1-3):111-6. PubMed ID: 19135050 [TBL] [Abstract][Full Text] [Related]
6. Local delivery of PKCepsilon-activating peptide mimics ischemic preconditioning in aged hearts through GSK-3beta but not F1-ATPase inactivation. Korzick DH; Kostyak JC; Hunter JC; Saupe KW Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2056-63. PubMed ID: 17675573 [TBL] [Abstract][Full Text] [Related]
7. Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore. Obame FN; Plin-Mercier C; Assaly R; Zini R; Dubois-Randé JL; Berdeaux A; Morin D J Pharmacol Exp Ther; 2008 Jul; 326(1):252-8. PubMed ID: 18434587 [TBL] [Abstract][Full Text] [Related]
8. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore. Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017 [TBL] [Abstract][Full Text] [Related]
9. Rosuvastatin protects isolated hearts against ischemia-reperfusion injury: role of Akt-GSK-3β, metabolic environment, and mitochondrial permeability transition pore. Vélez DE; Mestre-Cordero VE; Hermann R; Perego J; Harriet S; Fernandez-Pazos MLM; Mourglia J; Marina-Prendes MG J Physiol Biochem; 2020 Feb; 76(1):85-98. PubMed ID: 31916218 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation. Clarke SJ; Khaliulin I; Das M; Parker JE; Heesom KJ; Halestrap AP Circ Res; 2008 May; 102(9):1082-90. PubMed ID: 18356542 [TBL] [Abstract][Full Text] [Related]
11. Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury. Imahashi K; Schneider MD; Steenbergen C; Murphy E Circ Res; 2004 Oct; 95(7):734-41. PubMed ID: 15345651 [TBL] [Abstract][Full Text] [Related]
12. N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta. Park SS; Zhao H; Jang Y; Mueller RA; Xu Z J Pharmacol Exp Ther; 2006 Jul; 318(1):124-31. PubMed ID: 16611852 [TBL] [Abstract][Full Text] [Related]
13. Xenon preconditioning: the role of prosurvival signaling, mitochondrial permeability transition and bioenergetics in rats. Mio Y; Shim YH; Richards E; Bosnjak ZJ; Pagel PS; Bienengraeber M Anesth Analg; 2009 Mar; 108(3):858-66. PubMed ID: 19224794 [TBL] [Abstract][Full Text] [Related]
14. Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection. Nishihara M; Miura T; Miki T; Tanno M; Yano T; Naitoh K; Ohori K; Hotta H; Terashima Y; Shimamoto K J Mol Cell Cardiol; 2007 Nov; 43(5):564-70. PubMed ID: 17931653 [TBL] [Abstract][Full Text] [Related]
15. Mitochondria and GSK-3beta in cardioprotection against ischemia/reperfusion injury. Miura T; Tanno M Cardiovasc Drugs Ther; 2010 Jun; 24(3):255-63. PubMed ID: 20490903 [TBL] [Abstract][Full Text] [Related]
16. Mitochondrial adenine nucleotide transport and cardioprotection. Das S; Steenbergen C J Mol Cell Cardiol; 2012 Feb; 52(2):448-53. PubMed ID: 21945520 [TBL] [Abstract][Full Text] [Related]
18. Translocation of glycogen synthase kinase-3β (GSK-3β), a trigger of permeability transition, is kinase activity-dependent and mediated by interaction with voltage-dependent anion channel 2 (VDAC2). Tanno M; Kuno A; Ishikawa S; Miki T; Kouzu H; Yano T; Murase H; Tobisawa T; Ogasawara M; Horio Y; Miura T J Biol Chem; 2014 Oct; 289(42):29285-96. PubMed ID: 25187518 [TBL] [Abstract][Full Text] [Related]
19. Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A. Onishi A; Miyamae M; Kaneda K; Kotani J; Figueredo VM Eur J Pharmacol; 2012 Jan; 675(1-3):40-6. PubMed ID: 22166375 [TBL] [Abstract][Full Text] [Related]
20. Roles of phospho-GSK-3β in myocardial protection afforded by activation of the mitochondrial K ATP channel. Terashima Y; Sato T; Yano T; Maas O; Itoh T; Miki T; Tanno M; Kuno A; Shimamoto K; Miura T J Mol Cell Cardiol; 2010 Nov; 49(5):762-70. PubMed ID: 20692265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]